These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
272 related items for PubMed ID: 33468464
21. Potent inhibition of arenavirus infection by a novel fusion inhibitor. Gowen BB, Naik S, Westover JB, Brown ER, Gantla VR, Fetsko A, Dagley AL, Blotter DJ, Anderson N, McCormack K, Henkel G. Antiviral Res; 2021 Sep; 193():105125. PubMed ID: 34197863 [Abstract] [Full Text] [Related]
22. Screening and identification of Lassa virus endonuclease-targeting inhibitors from a fragment-based drug discovery library. Lan X, Zhang Y, Jia X, Dong S, Liu Y, Zhang M, Guo J, Cao J, Guo Y, Xiao G, Wang W. Antiviral Res; 2022 Jan; 197():105230. PubMed ID: 34965446 [Abstract] [Full Text] [Related]
23. Characterization of the Glycoprotein Stable Signal Peptide in Mediating Pichinde Virus Replication and Virulence. Shao J, Liu X, Ly H, Liang Y. J Virol; 2016 Nov 15; 90(22):10390-10397. PubMed ID: 27630230 [Abstract] [Full Text] [Related]
24. Arenavirus extinction through lethal mutagenesis. de la Torre JC. Virus Res; 2005 Feb 15; 107(2):207-14. PubMed ID: 15649566 [Abstract] [Full Text] [Related]
25. A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins. Carnec X, Mateo M, Page A, Reynard S, Hortion J, Picard C, Yekwa E, Barrot L, Barron S, Vallve A, Raoul H, Carbonnelle C, Ferron F, Baize S. J Virol; 2018 Jun 15; 92(12):. PubMed ID: 29593043 [Abstract] [Full Text] [Related]
26. A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans. Botten J, Whitton JL, Barrowman P, Sidney J, Whitmire JK, Alexander J, Kotturi MF, Sette A, Buchmeier MJ. J Virol; 2010 Oct 15; 84(19):9947-56. PubMed ID: 20668086 [Abstract] [Full Text] [Related]
27. Screening and Identification of Lujo Virus Inhibitors Using a Recombinant Reporter Virus Platform. Welch SR, Spengler JR, Genzer SC, Chatterjee P, Flint M, Bergeron É, Montgomery JM, Nichol ST, Albariño CG, Spiropoulou CF. Viruses; 2021 Jun 28; 13(7):. PubMed ID: 34203149 [Abstract] [Full Text] [Related]
28. Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid. Vázquez-Calvo Á, Martín-Acebes MA, Sáiz JC, Ngo N, Sobrino F, de la Torre JC. Antiviral Res; 2013 Aug 28; 99(2):172-9. PubMed ID: 23735299 [Abstract] [Full Text] [Related]
29. Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library. Wang P, Liu Y, Zhang G, Wang S, Guo J, Cao J, Jia X, Zhang L, Xiao G, Wang W. J Virol; 2018 Aug 15; 92(16):. PubMed ID: 29899092 [Abstract] [Full Text] [Related]
40. A Map of the Arenavirus Nucleoprotein-Host Protein Interactome Reveals that Junín Virus Selectively Impairs the Antiviral Activity of Double-Stranded RNA-Activated Protein Kinase (PKR). King BR, Hershkowitz D, Eisenhauer PL, Weir ME, Ziegler CM, Russo J, Bruce EA, Ballif BA, Botten J. J Virol; 2017 Aug 01; 91(15):. PubMed ID: 28539447 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]